ARTOVID-20® Tablets
Improving Life, Naturally
Immune Health
ARTOVID-20® Tablets
Stronger Immunity. Faster recovery. US Patented for treating Covid-19. Clinically validated through Phase III randomized human trials, Artovid-20® is a US-patented plant-based formulation designed to reduce inflammation and promote recovery, particularly during seasonal challenges.
Benefits: Supports immune defenses • Eases inflammation • Speeds recovery
US Patents, Clinical and Pre-Clinical Studies on ARTOVID-20® Tablets
- Chitre D. et al. (2023) United States Patent. Methods and Formulations for Treating and Preventing Long Haul Coronavirus (Long-COVID) Symptoms and Sequelae, Pub. No.:US 2023/0226082 AI. July 20, 2023. Methods and Formulations for Treating and Preventing Long Haul Coronavirus (Long-COVID) Symptoms and Sequelae,
- Chitre D. et al (2023) United States Patent. Methods and Compounds for Treating Effects of Covid-19 disease. Patent No.: US 11,628,197 B2. April 18, 2023. United States Patent. Methods and Compounds for Treating Effects of Covid-19 disease,
- Chitre D. et al. (2022). Phase III randomized clinical trial of BV-4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV-2 infections and its impact on inflammatory biomarkers. Phytotherapy Research, 1–10. https://doi.org/10.1002/ptr.7683. Randomized Clinical Trial of an Ayurvedic Formulation, BV-7310 in Alcoholic Liver Disease.
Contact us
-
1929 O’ Toole Way,
San Jose, CA 95131. USA. - +1 408 432 4020
- [email protected]
North Americas
South Americas
Asia
South East Asia
